Bioxytran, Inc
BIXT· OTC
BIXTBioxytran, Inc
Filed Aug 14, 2012 · 10-Q · 45 days after period end · 0001213900-12-004591
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $118.77K | $32.09K | $6.48K |
| Net Income | -$202.77K | -$141.49K | -$122.50K |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 14, 2012 · 45 d after period end
